Interview with Craig Moore, Director, Hahn Healthcare
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service providers to the industry such as Hahn? As service…
Address: Level 7, 50 Berry Street
North Sydney NSW 2060
Tel: 02 9959 5533
Web: http://www.hahnhealthcare.com.au/default.aspx
Hahn Healthcare combines innovative solutions and world-class services with market insight to create value in your business.
Hahn Healthcare offers clients access to: the highest quality people, industry leading solutions, innovative services, and new market opportunities.
Founded in 1994, Hahn Healthcare is a trusted partner with a reputation for excellence.
Innovative solutions. Market insight. Trusted Partnerships.
As a market leader, Hahn Healthcare is a trusted partner of key decision makers in the Australian pharmaceutical and medical device industries.
We are uniquely positioned to identify partner organisations and market opportunities for global healthcare products, including pharmaceutical and medical devices.
Our team partners with international companies to deliver global solutions locally. We provide strategic advice based on deep industry knowledge and create an access point to the Australian market.
Hahn Healthcare helps international companies reduce risk, manage regulatory requirements and create new revenue streams by facilitating the delivery of global solutions to the Australian marketplace.
Hahn Healthcare is committed to excellence. We build partnerships based on integrity, mutual respect and trust. We are transparent, accountable and operate according to the highest professional standards.
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service providers to the industry such as Hahn? As service…
To begin, would you please introduce Medicines Australia to Pharmaceutical Executive readers? Medicines Australia is the national industry association for innovative pharmaceutical companies. . Just about every company engaged in…
What impact have the PBS reforms had on Nycomed? As most mid size Pharma companies that operate in a setting of mass market prescription medicines, Nycomed is also experiencing the…
New Government health priorities and policies, highlighting those concerning preventive health. The Rudd Labor Government’s goal in health is to create a modern health system designed for the health needs…
How have your experiences at Quintiles, Astra, Baxter, and Innovex – covering the spectrum from small to large pharma in addition to the service side – helped in managing IMS…
Pharmacor is one of the newest entities on the Australian pharmaceutical market. Would you please introduce the company to let Pharmaceutical Executive readers understand more about the Pharmacor story? Pharmacare…
Would you please introduce the PBAC and the role it plays in Australia’s pharmaceutical sector? The Pharmaceutical Benefits Advisory Committee (PBAC) is a statutory committee of the Australian government which…
Molteni was created in 1892 and progressively developed a strong manufacturing base, a very active R&D department and a growing international presence. Could you introduce the story behind such achievements?…
To begin, would you please introduce Medicines Australia to Pharmaceutical Executive readers? Medicines Australia is the association that represents the country’s research-based pharmaceutical industry. With approximately 50 members, the organization…
Servier was eligible to receive $7 million in P3 funding; can you tell us how this initiative has helped the company? P3 was not one of the main reasons why…
Your distinguished career in health research leadership and management has seen you through a variety of prestigious positions, not to mention the Order of Australia. Most recently you were appointed…
Australia, the “land down under” to many Westerners, is sometimes left at just that — out of sight, and out of mind. But investors who ignore Australia do so…
See our Cookie Privacy Policy Here
